STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 55 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,449,000 | -1.2% | 135,420 | 0.0% | 1.56% | +8.0% |
| Q3 2016 | $1,467,000 | +60.0% | 135,420 | 0.0% | 1.44% | +51.9% |
| Q2 2016 | $917,000 | +45.3% | 135,420 | 0.0% | 0.95% | +73.4% |
| Q1 2016 | $631,000 | -26.2% | 135,420 | 0.0% | 0.55% | +6.0% |
| Q4 2015 | $855,000 | -78.5% | 135,420 | -70.0% | 0.52% | -49.4% |
| Q3 2015 | $3,986,000 | -25.0% | 451,400 | 0.0% | 1.02% | -31.8% |
| Q2 2015 | $5,313,000 | -18.7% | 451,400 | 0.0% | 1.50% | -0.3% |
| Q1 2015 | $6,532,000 | +7.4% | 451,400 | +26.7% | 1.50% | -10.1% |
| Q4 2014 | $6,080,000 | +587.8% | 356,400 | +402.0% | 1.67% | +321.4% |
| Q3 2014 | $884,000 | -25.8% | 71,000 | +42.0% | 0.40% | -55.1% |
| Q2 2013 | $1,192,000 | – | 50,000 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 762,941 | $7,248,000 | 7.29% |
| NEXTHERA CAPITAL LP | 711,558 | $6,760,000 | 2.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 585,930 | $4,366,000 | 2.71% |
| Consonance Capital Management LP | 1,155,793 | $10,980,000 | 0.81% |
| Pier Capital, LLC | 423,667 | $4,025,000 | 0.80% |
| KNOTT DAVID M | 155,795 | $1,480,000 | 0.70% |
| Eventide Asset Management | 1,086,400 | $10,321,000 | 0.46% |
| Empire Life Investments Inc. | 373,863 | $3,552,000 | 0.32% |
| Telemetry Investments, L.L.C. | 41,588 | $395,000 | 0.25% |
| Polar Capital LLP | 2,302,666 | $21,875,000 | 0.23% |